Tom Dønnem
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 35
- Cancer Immunotherapy and Biomarkers 19
- Cancer Cells and Metastasis 7
-
- MicroRNA in disease regulation 16
- Cancer, Hypoxia, and Metabolism 10
- Cancer-related molecular mechanisms research 9
- Co-authors
- Roy M. Bremnes (88 shared papers)Lill‐Tove Busund (88 shared papers)Samer Al‐Saad (59 shared papers)Sigve Andersen (73 shared papers)Khalid Al‐Shibli (37 shared papers)Elin Richardsen (40 shared papers)Thomas K. Kilvær (38 shared papers)Magnus Persson (6 shared papers)
- Journals
- PLoS ONE (15 papers)Scientific Reports (12 papers)Journal of Thoracic Oncology (8 papers)BMC Clinical Pathology (5 papers)Lung Cancer (5 papers)
- Partner nations
- NorwayUnited KingdomUnited States
In The Last Decade
Tom Dønnem
106 papers receiving 5.7k citations
Tom Dønnem's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 1.4k
- Oncology 2.5k
- Immunology 1.2k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 1.8k
Countries citing papers authored by Tom Dønnem
This map shows the geographic impact of Tom Dønnem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Dønnem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Dønnem more than expected).
Fields of papers citing papers by Tom Dønnem
This network shows the impact of papers produced by Tom Dønnem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Dønnem. The network helps show where Tom Dønnem may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Dønnem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer Hit paper breakdown → | 2010 | 536 |
| 2 | Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer Hit paper breakdown → | 2008 | 503 |
| 3 | 2016 | 364 | |
| 4 | 2010 | 279 | |
| 5 | 2015 | 255 | |
| 6 | 2013 | 206 | |
| 7 | 2019 | 120 | |
| 8 | 2008 | 115 | |
| 9 | 2010 | 112 | |
| 10 | 2018 | 110 | |
| 11 | 2007 | 99 | |
| 12 | 2008 | 98 | |
| 13 | 2011 | 97 | |
| 14 | 2014 | 93 | |
| 15 | 2012 | 92 | |
| 16 | 2009 | 86 | |
| 17 | 2011 | 80 | |
| 18 | 2015 | 74 | |
| 19 | 2017 | 73 | |
| 20 | 2016 | 72 |
About Tom Dønnem
Tom Dønnem is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 110 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), MicroRNA in disease regulation (16 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer-related molecular mechanisms research (9 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer Cells and Metastasis (7 papers), Immune cells in cancer (7 papers) and Angiogenesis and VEGF in Cancer (7 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (2.5k citations), Immunology (1.2k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Molecular Biology (1.8k citations). Tom Dønnem has collaborated with scholars based in Norway, United Kingdom and United States. Frequent co-authors include Roy M. Bremnes, Lill‐Tove Busund, Samer Al‐Saad, Sigve Andersen, Khalid Al‐Shibli, Elin Richardsen, Thomas K. Kilvær, Magnus Persson, Mehrdad Rakaee and Helge Stenvold. Their work appears in journals such as PLoS ONE, Scientific Reports, Journal of Thoracic Oncology, BMC Clinical Pathology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.